MedPath
FDA Approval

Indium In 111 Oxyquinoline

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
BWXT Medical Ltd.
DUNS: 203794185
Effective Date
May 5, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Indium In 111 Oxyquinoline

Product Details

NDC Product Code
72536-0920
Application Number
ANDA202586
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
July 5, 2019
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 7.5 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 100 ug in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: LGX9OL562TClass: ACTIMQuantity: 1 mCi in 1 mL
HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACIDInactive
Code: RWW266YE9IClass: IACTQuantity: 6 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath